The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index.
Multifaceted link between cancer and inflammation
Abstract
Increasing evidence from epidemiological, preclinical and clinical studies suggests that dysregulated inflammatory response plays a pivotal role in a multitude of chronic ailments including cancer. The molecular mechanism(s) by which chronic inflammation drives cancer initiation and promotion include increased production of pro-inflammatory mediators, such as cytokines, chemokines, reactive oxygen intermediates, increased expression of oncogenes, COX-2 (cyclo-oxygenase-2), 5-LOX (5-lipoxygenase) and MMPs (matrix metalloproteinases), and pro-inflammatory transcription factors such as NF-κB (nuclear factor κB), STAT3 (signal transducer and activator of transcription 3), AP-1 (activator protein 1) and HIF-1α (hypoxia-inducible factor 1α) that mediate tumour cell proliferation, transformation, metastasis, survival, invasion, angiogenesis, chemoresistance and radioresistance. These inflammation-associated molecules are activated by a number of environmental and lifestyle-related factors including infectious agents, tobacco, stress, diet, obesity and alcohol, which together are thought to drive as much as 90% of all cancers. The present review will focus primarily on the role of various inflammatory intermediates responsible for tumour initiation and progression, and discuss in detail the critical link between inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Mammalian MAP kinase signalling cascades
Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,111
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Cancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,588
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
The Interleukin-8 Pathway in Cancer
Waugh, D. J. J., & Wilson, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4843 · Cited by 2,103
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
Tumour necrosis factor and cancer
Balkwill, F. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2628 · Cited by 1,915
Marnett, L. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.361 · Cited by 1,883
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
Balkwill, F., Charles, K. A., & Mantovani, A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.013 · Cited by 1,769
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Molecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Reflecting on 25 years with MYC
Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
STATs: Signal Transducers and Activators of Transcription
Ihle, J. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81277-5 · Cited by 1,381
Inflammation and cancer: how hot is the link?
Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., & Sethi, G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.029 · Cited by 1,312
Self-citationMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
The origin and function of tumor-associated macrophages
Mantovani, A., Bottazzi, B., Colotta, F., Sozzani, S., & Ruco, L. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90008-u · Cited by 1,089
Phagocytes and oxidative stress
Babior, B. M. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00481-2 · Cited by 1,061
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Croce, C. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072367 · Cited by 1,055
Inflammation, a Key Event in Cancer Development
Lu, H., Ouyang, W., & Huang, C. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0261 · Cited by 1,028
Oxidative Stress and Oxidative Damage in Carcinogenesis
Klaunig, J. E., Kamendulis, L. M., & Hocevar, B. A. (2010) · Toxicologic Pathology · doi:10.1177/0192623309356453 · Cited by 957
Innate Immunity Gone Awry: Linking Microbial Infections to Chronic Inflammation and Cancer
Karin, M., Lawrence, T., & Nizet, V. (2006) · Cell · doi:10.1016/j.cell.2006.02.016 · Cited by 942
TNF-α in promotion and progression of cancer
Balkwill, F. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9005-3 · Cited by 915
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
Interleukin-17 promotes angiogenesis and tumor growth
Numasaki, M. (2003) · Blood · doi:10.1182/blood-2002-05-1461 · Cited by 834
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730
Biswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways
Schetter, A. J., Heegaard, N. H. H., & Harris, C. C. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp272 · Cited by 657
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
Mantovani, A. (2009) · Nature · doi:10.1038/457036b · Cited by 643
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., Marinkovich, M. P., Tao, S., Lin, Q., Kubo, Y., et al. (2003) · Nature · doi:10.1038/nature01283 · Cited by 535
Soucek, L., Lawlor, E. R., Soto, D., Shchors, K., Swigart, L. B., & Evan, G. I. (2007) · Nature Medicine · doi:10.1038/nm1649 · Cited by 507
The Hypoxic Response: Huffing and HIFing
Guillemin, K., & Krasnow, M. A. (1997) · Cell · doi:10.1016/s0092-8674(00)80176-2 · Cited by 478
Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours
Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
Eferl, R., Ricci, R., Kenner, L., Zenz, R., David, J.-P., Rath, M., & Wagner, E. F. (2003) · Cell · doi:10.1016/s0092-8674(03)00042-4 · Cited by 474
RET tyrosine kinase signaling in development and cancer
Arighi, E., Borrello, M. G., & Sariola, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.05.010 · Cited by 468
TNF: A master switch for inflammation to cancer
Sethi, G. (2008) · Frontiers in Bioscience · doi:10.2741/3066 · Cited by 458
Self-citationInflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Saccani, A., Schioppa, T., Porta, C., Biswas, S. K., Nebuloni, M., Vago, L., Bottazzi, B., Colombo, M. P., Mantovani, A., & Sica, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1867 · Cited by 455
The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
Angel, P., & Karin, M. (1991) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(91)90011-9 · Cited by 450
Transcription Factor NF‐κB: A Sensor for Smoke and Stress Signals
AHN, K. S., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.026 · Cited by 432
He, G., Yu, G.-Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H. L., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.048 · Cited by 427
AP-1 — The Jun proteins: Oncogenes or tumor suppressors in disguise?
Shaulian, E. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.008 · Cited by 425
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
Ancrile, B., Lim, K.-H., & Counter, C. M. (2007) · Genes & Development · doi:10.1101/gad.1549407 · Cited by 422
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Self-citationNumasaki, M., Watanabe, M., Suzuki, T., Takahashi, H., Nakamura, A., McAllister, F., Hishinuma, T., Goto, J., Lotze, M. T., Kolls, J. K., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6177 · Cited by 416
Molecular Pathways Linking Inflammation and Cancer
Mantovani, A. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316968 · Cited by 414
Inflammation and cancer: how friendly is the relationship for cancer patients?
Aggarwal, B. B., & Gehlot, P. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.06.020 · Cited by 405
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Self-citationAGGARWAL, B. B., SETHI, G., AHN, K. S., SANDUR, S. K., PANDEY, M. K., KUNNUMAKKARA, A. B., SUNG, B., & ICHIKAWA, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.063 · Cited by 398
Self-citationYoung, M. R., Li, J.-J., Rincón, M., Flavell, R. A., Sathyanarayana, B. K., Hunziker, R., & Colburn, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9827 · Cited by 382
Stat3 regulates genes common to both wound healing and cancer
Dauer, D. J., Ferraro, B., Song, L., Yu, B., Mora, L., Buettner, R., Enkemann, S., Jove, R., & Haura, E. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208469 · Cited by 380
Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice
Yoneda, J., Kuniyasu, H., Price, J. E., Bucana, C. D., Fidler, I. J., & Crispens, M. A. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.447 · Cited by 375
Interleukin‐6 and its receptor in cancer: Implications for Translational Therapeutics
Hong, D. S., Angelo, L. S., & Kurzrock, R. (2007) · Cancer · doi:10.1002/cncr.22999 · Cited by 370
Huang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X.-D., Gudas, J. M., & Bar-Eli, M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64164-8 · Cited by 361
Serum interleukin‐6 levels reflect the disease status of colorectal cancer
Chung, Y., & Chang, Y. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10269 · Cited by 353
Ernst, M., Najdovska, M., Grail, D., Lundgren-May, T., Buchert, M., Tye, H., Matthews, V. B., Armes, J., Bhathal, P. S., Hughes, N. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34944 · Cited by 350
Inflammation and the development of pancreatic cancer
Farrow, B., & Evers, B. M. (2002) · Surgical Oncology · doi:10.1016/s0960-7404(02)00015-4 · Cited by 338
Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron, S. L., Edwards, S. M., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A., Southgate, C., Easton, D. F., Eeles, R. A., & Howell, W. M. (2002) · PubMed · Cited by 336
Evans, J. F., Oshima, M., Murai, N., Kargman, S., Arguello, M., Luk, P., Kwong, E., & Taketo, M. M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02780.x · Cited by 333
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono, T., Tofilon, P. J., Bruner, J. M., Owolabi, O., & Lang, F. F. (2001) · PubMed · Cited by 332
Cancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
Souza, R. F., Shewmake, K., Beer, D. G., Cryer, B., & Spechler, S. J. (2000) · PubMed · Cited by 315
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Self-citationTargeting NRF2 signaling for cancer chemoprevention
Kwak, M.-K., & Kensler, T. W. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.08.028 · Cited by 305
NF‐κB and cancer: Mechanisms and targets
Karin, M. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20217 · Cited by 298
Lipoxygenase metabolism: roles in tumor progression and survival
Pidgeon, G. P., Lysaght, J., Krishnamoorthy, S., Reynolds, J. V., O’Byrne, K., Nie, D., & Honn, K. V. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9098-3 · Cited by 295
Lipoxygenase modulation to reverse carcinogenesis.
Shureiqi, I., & Lippman, S. M. (2001) · PubMed · Cited by 292
Serum interleukin-6 levels in colorectal cancer patients—a summary of published results
Knüpfer, H., & Preiss, R. (2010) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0818-8 · Cited by 291
Tartour, É., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E. J., Sastre‐Garau, X., Couturier, J., Mosseri, V., Vives, V., et al. (1999) · PubMed · Cited by 290
Transcription factors control invasion: AP-1 the first among equals
Ozanne, B. W., Spence, H. J., McGarry, L. C., & Hennigan, R. F. (2007) · Oncogene · doi:10.1038/sj.onc.1209759 · Cited by 287
Expression of cyclooxygenase 2 in human malignant melanoma.
Denkert, C., Köbel, M., Berger, S. M., Siegert, A., Leclere, A., Trefzer, U., & Hauptmann, S. (2001) · PubMed · Cited by 287
Zhang, S., Cordon‐Cardo, C., Zhang, H. S., Reuter, V. E., Adluri, S., Hamilton, W. B., Lloyd, K. O., & Livingston, P. O. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970926)73:1<94::aid-ijc15>3.0.co;2-5 · Cited by 286
NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Shen, H.-M., & Tergaonkar, V. (2009) · Apoptosis · doi:10.1007/s10495-009-0315-0 · Cited by 275
Self-citationA Genetically Defined Model for Human Ovarian Cancer
Liu, J., Yang, G., Thompson-Lanza, J. A., Glassman, A., Hayes, K., Patterson, A., Marquez, R. T., Auersperg, N., Yu, Y., Hahn, W. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3380 · Cited by 273
Potential of Spice-Derived Phytochemicals for Cancer Prevention
Aggarwal, B., Kunnumakkara, A., Harikumar, K., Tharakan, S., Sung, B., & Anand, P. (2008) · Planta Medica · doi:10.1055/s-2008-1074578 · Cited by 269
Xu, S., & Lam, K.-P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.4067-4074.2001 · Cited by 267
The IκB kinase – a bridge between inflammation and cancer
Karin, M. (2008) · Cell Research · doi:10.1038/cr.2008.30 · Cited by 259
Role of Reactive Oxygen Species in Skin Carcinogenesis
Nishigori, C., Hattori, Y., & Toyokuni, S. (2004) · Antioxidants & Redox Signaling · doi:10.1089/152308604773934314 · Cited by 258
Kim, S. Y., Lee, C. H., Midura, B. V., Yeung, C., Mendoza, A., Hong, S. H., Ren, L., Wong, D., Korz, W., Merzouk, A., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9133-3 · Cited by 253
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Cancer and Inflammation: Implications for Pharmacology and Therapeutics
Balkwill, F., & Mantovani, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.312 · Cited by 249
Saijo, Y., Tanaka, M., Miki, M., Usui, K., Suzuki, T., Maemondo, M., Hong, X., Tazawa, R., Kikuchi, T., Matsushima, K., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.469 · Cited by 249
Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Dispenzieri, A., Gertz, M. A., Witzig, T. E., Kumar, S., Hayman, S. R., Russell, S. J., Buadi, F. K., et al. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.2.114 · Cited by 246
Bendre, M. S., Margulies, A. G., Walser, B., Akel, N. S., Bhattacharrya, S., Skinner, R. A., Swain, F., Ramani, V., Mohammad, K. S., Wessner, L. L., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2630 · Cited by 243
Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells.
Xu, L., & Fidler, I. J. (2000) · PubMed · Cited by 241
Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
Teo, H., Ghosh, S., Luesch, H., Ghosh, A., Wong, E. T., Malik, N., Orth, A., de Jesus, P., Perry, A. S., Oliver, J. D., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2080 · Cited by 222
Self-citationWolf, J., Chen, Z., Dong, G., Sunwoo, J. B., Bancroft, C. C., Capo, D. E., Yeh, N. T., Mukaida, N., & Waes, C. V. (2001) · PubMed · Cited by 215
Targeting the hypoxia-inducible factor (HIF) pathway in cancer
Poon, E., Harris, A. L., & Ashcroft, M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409001173 · Cited by 213
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 207
Self-citationHIF-1 in the inflammatory microenvironment
Dehne, N., & Brüne, B. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.03.019 · Cited by 206
Oxygen Free Radicals and the Systemic Inflammatory Response
Closa, D., & Folch‐Puy, E. (2004) · IUBMB Life · doi:10.1080/15216540410001701642 · Cited by 205
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 203
The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1β
Shchors, K., Shchors, E., Rostker, F., Lawlor, E. R., Brown-Swigart, L., & Evan, G. I. (2006) · Genes & Development · doi:10.1101/gad.1455706 · Cited by 200
Maxwell, P. J., Gallagher, R., Seaton, A., Wilson, C., Scullin, P., Pettigrew, J., Stratford, I. J., Williams, K. J., Johnston, P. G., & Waugh, D. J. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210536 · Cited by 199
Enhancement of experimental metastasis by tumor necrosis factor.
Orosz, P., Echtenacher, B., Falk, W., Rüschoff, J., Weber, D., & Männel, D. N. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1391 · Cited by 198
Roles of NF-κB in health and disease: mechanisms and therapeutic potential
Wong, E. T., & Tergaonkar, V. (2009) · Clinical Science · doi:10.1042/cs20080502 · Cited by 196
Self-citationFerrajoli, A., Keating, M. J., Manshouri, T., Giles, F. J., Dey, A., Estrov, Z., Koller, C. A., Kurzrock, R., Thomas, D. A., Faderl, S., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1215.h81602001215_1215_1219 · Cited by 191
Kundu, N., & Fulton, A. M. (2002) · PubMed · Cited by 189
Su, J.-L., Shih, J.-Y., Yen, M.-L., Jeng, Y.-M., Chang, C.-C., Hsieh, C.-Y., Wei, L.-H., Yang, P.-C., & Kuo, M.-L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1301 · Cited by 189
Arredondo, J., Chernyavsky, A. I., Jolkovsky, D. L., Pinkerton, K. E., & Grando, S. A. (2006) · The FASEB Journal · doi:10.1096/fj.06-6191com · Cited by 182
The Role of Cyclooxygenase and Lipoxygenase in Cancer Chemoprevention
Cuendet, & Pezzuto (2000) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2000.17.1-4.109 · Cited by 182
Wang, Z. Q., Grigoriadis, A. E., Möhle-Steinlein, U., & Wagner, E. F. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07783.x · Cited by 176
Stoilova-McPhie, S., Villoutreix, B. O., Mertens, K., Kemball-Cook, G., & Holzenburg, A. (2002) · Blood · doi:10.1182/blood.v99.4.1215 · Cited by 174
Arlt, A., Vorndamm, J., Müerköster, S. S., Yu, H., Schmidt, W. E., Fölsch, U. R., & Schäfer, H. (2002) · PubMed · Cited by 173
WIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Self-citationPotential pharmacological control of the NF-κB pathway
Sethi, G., & Tergaonkar, V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.004 · Cited by 171
Self-citationMutations of the p53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis
Shen, H.-M., & Ong, C.-N. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90005-6 · Cited by 171
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 169
Self-citationBos, T. J., Monteclaro, F. S., Mitsunobu, F., Ball, A. R., Chang, C. H., Nishimura, T., & Vogt, P. K. (1990) · Genes & Development · doi:10.1101/gad.4.10.1677 · Cited by 169
Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4
Young, M. R., Yang, H.-S., & Colburn, N. H. (2003) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)00009-6 · Cited by 166
Oncogenes and tumor suppressor genes
Weinberg, R. A. (1994) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.44.3.160 · Cited by 165
Pǒld, M., Zhu, L. X., Sharma, S. P., Burdick, M. D., Lin, Y., Lee, P. P. N., Põld, A., Luo, J., Krysan, K., Dohadwala, M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3262 · Cited by 160
Phosphoproteome dynamics reveal novel ERK1/2 MAP kinase substrates with broad spectrum of functions
Courcelles, M., Frémin, C., Voisin, L., Lemieux, S., Meloche, S., & Thibault, P. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.25 · Cited by 158
Deciphering AP-1 Function in Tumorigenesis: Fra-ternizing on Target Promoters
Verde, P., Casalino, L., Talotta, F., Yaniv, M., & Weitzman, J. B. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4850 · Cited by 155
Bronte-Tinkew, D. M., Terebiznik, M., Franco, A., Ang, M., Ahn, D., Mimuro, H., Sasakawa, C., Ropeleski, M. J., Peek, R. M., & Jones, N. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1191 · Cited by 154
Distinct roles of IκB proteins in regulating constitutive NF-κB activity
Tergaonkar, V., Correa, R. G., Ikawa, M., & Verma, I. M. (2005) · Nature Cell Biology · doi:10.1038/ncb1296 · Cited by 152
Self-citationThe role of chemokines in intestinal inflammation and cancer
Wang, D., DuBois, R. N., & Richmond, A. J. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.003 · Cited by 152
Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke
Ye, Y. N., Wu, W. K. K., Shin, V. Y., Bruce, I. C., Wong, B. C. Y., & Cho, C. H. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi012 · Cited by 152
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 149
Self-citationAP-1 a Target for Cancer Prevention
Matthews, C. P., Colburn, N. H., & Young, M. R. (2007) · Current Cancer Drug Targets · doi:10.2174/156800907780809723 · Cited by 147
Li, Y., Du, H., Qin, Y., Roberts, J., Cummings, O. W., & Yan, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0647 · Cited by 146
Analysis of Cyclooxygenase 2 (COX-2) Expression During Malignant Melanoma Progression
Goulet, A.-C., Einsphar, J., Alberts, D. S., Beas, A. O., Burk, C., Bhattacharyya, A. K., Bangert, J. L., Harmon, J. M., Fujiwara, H., Koki, A. T., et al. (2003) · Cancer Biology & Therapy · doi:10.4161/cbt.2.6.627 · Cited by 145
Cytokine Network in Human Multiple Myeloma
Klein, B., & Bataille, R. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30344-7 · Cited by 145
Nabors, B., Suswam, E. A., Huang, Y., Yang, X., Johnson, M. J., & King, P. H. (2003) · PubMed · Cited by 139
The Role of Tissue Inhibitors of Metalloproteinases in Tumorigenesis and Metastasis
Cruz‐Muñoz, W., & Khokha, R. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360801973244 · Cited by 137
Liu, W., Reinmuth, N., Stoeltzing, O., Parikh, A. A., Tellez, C. S., Williams, S. A., Jung, Y. D., Fan, F., Takeda, A., Akagi, M., et al. (2003) · PubMed · Cited by 135
Li, J. J., Rhim, J. S., Schlegel, R., Vousden, K. H., & Colburn, N. H. (1998) · Oncogene · doi:10.1038/sj.onc.1201798 · Cited by 126
Clinical and experimental approaches to the pathophysiology of interleukin-18 in cancer progression
Vidal‐Vanaclocha, F., Mendoza, L., Tellería, N., Salado, C., Valcárcel, M., Gallot, N., Carrascal, T., Egilegor, E., Beaskoetxea, J., & Dinarello, C. A. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9013-3 · Cited by 122
Nuclear Factor-Kappa B: From Clone to Clinic
Ahn, K., Sethi, G., & Aggarwal, B. B. (2007) · Current Molecular Medicine · doi:10.2174/156652407782564363 · Cited by 122
Self-citationTang, X., Sun, Y. J., Half, E., Kuo, M. T., & Sinicrope, F. A. (2002) · PubMed · Cited by 119
Subbarayan, V., Sabichi, A. L., Llansa, N., Lippman, S. M., & Menter, D. G. (2001) · PubMed · Cited by 115
Kim, Y. B., Kim, G. E., Cho, N. H., Pyo, H. R., Shim, S. J., Chang, S. K., Park, H. C., Suh, C., Park, T. K., & Kim, B. (2002) · Cancer · doi:10.1002/cncr.10684 · Cited by 113
Role for MyD88-Independent, TRIF Pathway in Lipid A/TLR4-Induced Endotoxin Tolerance
Biswas, S. K., Bist, P., Dhillon, M. K., Kajiji, T., del Fresno, C., Yamamoto, M., López‐Collazo, E., Akira, S., & Tergaonkar, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4083 · Cited by 113
Self-citationModulation of CXCL14 (BRAK) expression in prostate cancer
Schwarze, S. R., Luo, J., Isaacs, W. B., & Jarrard, D. F. (2005) · The Prostate · doi:10.1002/pros.20215 · Cited by 112
Briggs, J., Chamboredon, S., Castellazzi, M., Kerry, J. A., & Bos, T. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205857 · Cited by 111
Inflammation and Cancer: Is the Link as Simple as We Think?
Nickoloff, B. J., Ben-Neriah, Y., & Pikarsky, E. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23724.x · Cited by 110
The Prostaglandin E2 Receptor EP2 Is Required for Cyclooxygenase 2–Mediated Mammary Hyperplasia
Chang, S.-H., Ai, Y., BREYER, R. M., Lane, T. F., & Hla, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0129 · Cited by 109
Inflammation and cancer: The oncogene-driven connection
Borrello, M. G., Degl’Innocenti, D., & Pierotti, M. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.060 · Cited by 106
Kai, H., Kitadai, Y., Kodama, M., Cho, S., Kuroda, T., Ito, M., Tanaka, S., Ohmoto, Y., & Chayama, K. (2005) · PubMed · Cited by 106
Schmiegel, W., Roeder, C., Schmielau, J., Rodeck, U., & Kalthoff, H. (1993) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.90.3.863 · Cited by 104
Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer
Sharma, R., Zucknick, M., London, R. M., Kacevska, M., Liddle, C., & Clarke, S. J. (2008) · Clinical Colorectal Cancer · doi:10.3816/ccc.2008.n.044 · Cited by 103
Sano, S., Chan, K. S., Kira, M., Kataoka, K., Takagi, S., Tarutani, M., Itami, S., Kiguchi, K., Yokoi, M., Sugasawa, K., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4359 · Cited by 103
G-308A TNF-α polymorphism is associated with an increased risk of invasive cervical cancer
Duarte, I., Santos, A. M., de Sousa, H. M. L., Catarino, R., Pinto, D., Matos, A., Pereira, D., Moutinho, J., Canedo, P., Machado, J. C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.137 · Cited by 98
Stromal Cell-Derived Factor-1 Promotes Cell Migration, Tumor Growth of Colorectal Metastasis
Kollmar, O., Rupertus, K., Scheuer, C., Junker, B., Tilton, B., Schilling, M. K., & Menger, M. D. (2007) · Neoplasia · doi:10.1593/neo.07559 · Cited by 98
Up-Regulation of Functional Chemokine Receptor CCR3 in Human Renal Cell Carcinoma
Jöhrer, K., Zelle‐Rieser, C., Perathoner, A., Moser, P. L., Hager, M., Ramoner, R. E., Gander, H., Höltl, L., Bartsch, G. H., Greil, R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0405 · Cited by 98
p53 and NF-κB Crosstalk: IKKα Tips the Balance
Tergaonkar, V., & Perkins, N. D. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.006 · Cited by 97
Self-citationGu, Z., Li, J., Li, M., Gu, J., Shi, X., Ke, Y., & Chen, K. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50018.x · Cited by 96
DNA Damage, a Biomarker of Carcinogenesis: Its Measurement and Modulation by Diet and Environment
Hwang, E., & Bowen, P. E. (2007) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390600550299 · Cited by 96
Melisi, D., Niu, J., Chang, Z., Xia, Q., Peng, B., Ishiyama, S., Evans, D. B., & Chiao, P. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0201 · Cited by 95
Porcile, C., Bajetto, A., Barbero, S., PIRANI, P., & Schettini, G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1329.021 · Cited by 92
Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
Angelo, L. S., Talpaz, M., & Kurzrock, R. (2002) · PubMed · Cited by 91
Kimsey, T. F., Campbell, A. S., Albo, D., & Wang, T. N. (2004) · The Cancer Journal · doi:10.1097/00130404-200411000-00007 · Cited by 90
Alterations in NF B Activation in T Lymphocytes of Patients With Renal Cell Carcinoma
Uzzo, R. G., Clark, P., Rayman, P. A., Bloom, T., Rybicki, L. A., Novick, A. C., Bukowski, R. M., & Finke, J. H. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.8.718 · Cited by 88
Koh, M. Y., Spivak-Kroizman, T. R., & Powis, G. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_3 · Cited by 86
Tumour necrosis factor α confers an invasive, transformed phenotype on mammary epithelial cells
Montesano, R., Soulié, P., Eble, J. A., & Carrozzino, F. (2005) · Journal of Cell Science · doi:10.1242/jcs.02467 · Cited by 83
5-Lipoxygenase, a Marker for Early Pancreatic Intraepithelial Neoplastic Lesions
Hennig, R., Grippo, P. J., Ding, X.-Z., Rao, S. M., Büchler, M. W., Friess, H., Talamonti, M., Bell, R. H., & Adrian, T. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4090 · Cited by 82
Aggarwal, B. B., Schwarz, L., Hogan, M. E., et al. (1996) · PubMed · Cited by 81
IL-8 expression in malignant melanoma: implications in growth and metastasis.
Singh, R. K., & Varney, M. L. (2000) · PubMed · doi:10.14670/hh-15.843 · Cited by 80
Boado, R. J., Pardridge, W. M., Vinters, H. V., & Black, K. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9044 · Cited by 78
Lee, K.-G., Xu, S., Wong, E.-T., Tergaonkar, V., & Lam, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708516200 · Cited by 77
Self-citationTsukasaki, K., Miller, C. W., Kubota, T., Takeuchi, S., Fujimoto, T., Ikeda, S., Tomonaga, M., & Koeffler, H. P. (2001) · PubMed · Cited by 76
Dey, A., Wong, E. T., Cheok, C. F., Tergaonkar, V., & Lane, D. P. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402257 · Cited by 73
Self-citationNutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy
Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70
Self-citationA role for IκB kinase 2 in bipolar spindle assembly
Irelan, J. T., Murphy, T. J., DeJesus, P., Teo, H., Xu, D., Gómez-Ferrería, M. A., Zhou, Y., Miraglia, L. J., Rines, D. R., Verma, I. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706493104 · Cited by 70
Self-citationSakata, K., Satoh, M., Someya, M., Asanuma, H., Nagakura, H., Oouchi, A., Nakata, K., Kogawa, K., Koito, K., Hareyama, M., et al. (2004) · Cancer · doi:10.1002/cncr.11905 · Cited by 70
Ye, Y.-N., Liu, E. S.-L., Shin, V. Y., Wu, W. K. K., & Cho, C. (2004) · Toxicology · doi:10.1016/j.tox.2004.06.004 · Cited by 67
Black, E. J., Clair, T., Delrow, J. J., Neiman, P. E., & Gillespie, D. A. (2003) · Oncogene · doi:10.1038/sj.onc.1207377 · Cited by 65
Th17 cells: A new therapeutic target in inflammatory dermatoses
Asarch, A., Barak, O. G., Loo, D. S., & Gottlieb, A. B. (2008) · Journal of Dermatological Treatment · doi:10.1080/09546630802206660 · Cited by 64
Jiang, W. G., Douglas-Jones, A. G., & Mansel, R. E. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.10.005 · Cited by 60
Cited by
TNF-α signalling and inflammation: interactions between old acquaintances
Zelová, H., & Hošek, J. (2013) · Inflammation Research · doi:10.1007/s00011-013-0633-0 · Cited by 853
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationThe Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationShanmugam, M. K., Dai, X., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.03.006 · Cited by 327
Self-citationChronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 317
Self-citation
Metadata
- Authors
- Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., & Tergaonkar, V.
- Venue
- Bioscience Reports
- Publisher
- Portland Press Ltd.
- Published
- 2011-09-26
- Volume
- 32
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0144-8463 (ISSN-L)
- 1573-4935
- OpenAlex
- W2029397966
- Cited by
- 333
- References
- 215
- FWCI
- 17.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.